Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Geoffrey Strobbe"'
Autor:
Diane Pannier, Ilyes Sakji, Geoffrey Strobbe, Frédéric Feutry, Alexandre Villain, Guillaume Marliot
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1743-1749
IntroductionDrug interactions involving everolimus are fairly well known because of its common use, primarily as an immunosuppressant. Several recommendations regarding therapeutic drug monitoring are also available for the use of everolimus-based im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::339a6a718b85bb5be23c45232c4c3762
https://doi.org/10.1177/1078155220904761
https://doi.org/10.1177/1078155220904761
Autor:
Geoffrey Strobbe, Félicie Fraipont, Sandra Raimbault, Sylvie Mercier, Thibault Stala, Marie Naveau, Alexandre Villain, Ilyes Sakji, Anne-Sophie Defachelles, Frédéric Feutry, Guillaume Marliot
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(7)
Introduction Mitotane (o, p′-DDD) is a molecule that was developed many years ago for adrenal cortical carcinoma, but no suitable pediatric dosage form is available for administration to young children. Mitotane requires therapeutic drug monitoring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c6cf23e823725462e97fc30b102610d
https://pubmed.ncbi.nlm.nih.gov/35098802
https://pubmed.ncbi.nlm.nih.gov/35098802
Autor:
Geoffrey Strobbe, Frédéric Feutry, Emilie Bogart, Guillaume Marliot, Alexandre Villain, Ilyes Sakji
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 5, Iss 1, Pp 40-6 (2020)
ObjectivesPreparation of 5-FU elastomeric pumps is a time-consuming activity inducing musculoskeletal disorders (MSDs). Our unit has developed an automated filling system consisting of two peristaltic pumps (one for the diluent, one for the cytotoxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6febda16383da50914c0ae62f8aa33b4
https://doi.org/10.1515/pthp-2020-0003
https://doi.org/10.1515/pthp-2020-0003
Publikováno v:
Acta Oncologica. 58:1167-1169
In our hospital center, in primary oral chemotherapy prescriptions for high-risk patients, clinical pharmacists participate in the introduction of a treatment by analyzing the risk of interaction b...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39f3fd10658d8af592b6f15f7cf6390b
https://doi.org/10.1080/0284186x.2019.1606936
https://doi.org/10.1080/0284186x.2019.1606936
Autor:
Jérôme Danklou, Geoffrey Strobbe, Stéphanie Delbey, Guillaume Marliot, Danièle Lefebvre-Kuntz
Publikováno v:
Bulletin du Cancer. 102:898-905
Resume Introduction La maladie thromboembolique veineuse represente une complication frequente au cours du cancer et en est la deuxieme cause de deces apres les infections. L’heparine de bas poids moleculaire est le traitement de premier choix dans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f35eb4868a593cc373dce16ab05349b4
https://doi.org/10.1016/j.bulcan.2015.09.003
https://doi.org/10.1016/j.bulcan.2015.09.003
Autor:
Jérôme, Danklou, Geoffrey, Strobbe, Stéphanie, Delbey, Danièle, Lefebvre-Kuntz, Guillaume, Marliot
Publikováno v:
Bulletin du cancer. 102(11)
Venous thromboembolism is a common complication in cancer and is the second cause of death below infection. Low molecular weight heparin is the gold standard in venous thromboembolism during cancer. This work aimed to evaluate the prevalence of presc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::59d1bb5f1744e0584723735a0d7afe88
https://pubmed.ncbi.nlm.nih.gov/26506036
https://pubmed.ncbi.nlm.nih.gov/26506036